Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2024
March 15, 2024 05:28 ET
|
Research and Markets
Dublin, March 15, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global acute...
Respiratory Drugs Market Projected to Expand by USD 30.23 Billion with a 6.38% CAGR by 2027
March 04, 2024 07:33 ET
|
Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Global Respiratory Drugs Market 2023-2027" report has been added to ResearchAndMarkets.com's offering. The global respiratory drugs market is...
Acute Respiratory Distress Syndrome Pipeline Report 2024: Insight Encompasses Over 50 Companies and Drug Profiles
February 27, 2024 11:07 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. Understanding the rapid...
Alpha-1 Antitrypsin Deficiency (AATD) Epidemiology Forecast to 2032 Across the 7MM
January 29, 2024 12:07 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This research offers a...
Levofloxacin Market Forecast Reveals Rapid Growth in Asia-Pacific Region and Advancements in Targeted Therapies
January 29, 2024 11:15 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Levofloxacin Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global attention turns to the recent...
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, 2023: High-Level Data, Leading Companies, Trial Outcomes, Enrollment Trends, and Latest Developments
January 25, 2024 08:19 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023" report has been added to ResearchAndMarkets.com's offering. This...
Global Idiopathic Pulmonary Fibrosis (IPF) Market Report 2024-2034: IPF Industry to Observe Robust Expansion with Emerging Therapies and Increasing Prevalence of Cough-Related IPF
January 25, 2024 07:29 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Cough in Idiopathic pulmonary fibrosis (IPF) - Market Insights, Epidemiology, and Market Forecast - 2034" report has been added to ...
Dry Powder Inhaler Devices Pipeline Analysis Report 2023: Stages of Development, Regulatory Pathways, Key Companies, Regional Insights
January 24, 2024 04:59 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies" report has been added to ...
Global Cystic Fibrosis Lung Disease Market Forecasts Promising Growth with Advances in Therapeutics to 2029
January 08, 2024 13:08 ET
|
Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Lung Disease Market: Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market...
PULMOZYME (Dornase Alfa) Drug Insights and Market Forecasts, 2019-2022 and 2023-2032: Focus on 7MM - United States, Germany, France, Italy, Spain, United Kingdom and Japan
December 14, 2023 10:23 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "PULMOZYME Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...